|
Gene and Protein Expression
|
Presenter(s)
|
Presentation
 |
Abstract
|
| A Al-Hendy M.D, Ph.D. (Department of Obstetrics and Gynecology,
University of Texas Medical Branch)
|
Gene Therapy of Uterine Fibroids: Adenovirus-Mediated Expression of Dominant
Negative Estrogen Receptor Inhibits ERE-Reporter Transactivation in Rat and
Human Leiomyoma Cells
|
Abstract |
| A Al-Hendy*, J Chiorini, and G Di Pasquale (Dept of Obstetrics and Gynecology,
University of Texas Medical Branch)
|
Towards Gene Therapy for Uterine Fibroids: Adeno-Associated Virus can Infect
Human and Rat Leiomyoma cells
|
Abstract |
| A Al-Hendy* and SA Salama (Dept of Obstetrics and Gynecology,
University of Texas Medical Branch)
|
A Functional Polymorphism in Catechol-O-Methyl Transferase Gene Explains
Increased Risk of Uterine Leiomyomas in Black Americans
|
Abstract |
| SA Salama* and A Al-Hendy (Dept of Obstetrics and Gynecology,
University of Texas Medical Branch)
|
Retinoic Acid Up-Regulates Catechol-O-Methyl Transferase Promoters: Potential
Mechanism for the Mitogenic Effect of Retinoic Acid on Leiomyomas Cells
|
Abstract |
| SA Salama* & A Al-Hendy (Department of Obstetrics and Gynecology, University of Texas Medical Branch)
|
Catechol-O-Methyl Transferase Inhibitors and 2-Methoxyestradiol Suppress
Leiomyoma Cell Proliferation: Potential Medical Therapy for Uterine Fibroids
|
Abstract |
| SA Salama*, H SL, HQ Wang, J Tenhunen, and A Al-Hendy (Department of Obstetrics & Gynecology, University of Texas Medical Branch)
|
Hormonal Regulation of Catechol-O-Methyl Transferase Activity in Uterine
Leiomyoma
|
Abstract |
| M Kamel*, SA Salama, G Christman and A Al-Hendy (Dept of Obstetrics and
Gynecology, University of Texas Medical Branch)
|
Uterine Fibroids Gene Therapy: Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir Treatment Inhibits Growth of Human and Rat Leiomyoma Cells
|
Abstract |
| AG Imir, Z Lin, H Utsunomiya, S Deb, B Yilmaz, SE Bulun (Northwestern University
Feinburg School of Medicine, Obstetrics and Gynecology)
|
Aromatase Expression in Uterine Leiomyomata is Regulated by Alternative
Promoters
|
Abstract |
Treatment
|
Presenter(s)
|
Presentation
|
Abstract
|
| SH Eisinger,* T Bonfiglio, K Fiscella, S Meldrum, DS Guzick. (University of Rochester School of Medicine & Dentistry)
|
Twelve Month Safety and Efficacy of Low Dose Mifepristone for Uterine Fibroids |
Abstract |
| OC Smart*, JT Hindley, WM Gedroyc, L Regan (St Mary’s Hospital and Imperial College School of Medicine, London.)
|
MR Guided Focused Ultrasound of Uterine Fibroids:
The Effects of GnRH Analogue Pre-Treatment |
Abstract |
| J Seibel-Seamon, A Ness, J Goldberg (Jefferson Medical College
Department of Obstetrics and Gynecology, Philadelphia, PA)
|
Uterine fibroid embolization complications in the scientific literature and the FDA’s
MAUDE database
|
Abstract |
In Vitro Drug Studies
|
Presenter(s)
|
Presentation
|
Abstract
|
| R Nowak*, P Low, J Wubben, and R Belton, Jr. (Dept. of Animal Sciences, University of Illinois)
|
Halofuginone Inhibits Proliferation and Collagen Production by Leiomyoma
Smooth Muscle Cells
|
Abstract |
| A Shushan*, N Rojansky, N Laufer, BY Klein and H Ben-Bassat (Department of
Obstetrics and Gynecology, Hadassah University Hospital, Jerusalem, Israel)
|
New EGF Receptor Inhibitors and Genistein for the Non-surgical Treatment of Leiomyomas
|
Abstract |
| H-J Tang, K Martel, JM Stribley, GM Christman*
(Dept of Obstetrics and Gynecology, Univ of Michigan)
|
The Effect of Resveratrol on Proliferation and
Apoptosis in Uterine Leiomyoma Cells
|
Abstract |
Epidemiology/Descriptive Studies
|
Presenter(s)
|
Presentation
|
Abstract
|
| JV Bromberg, J Goldberg*, K Rychlak, L Weinstein (Jefferson Fibroid Center
Department of Obstetrics and Gynecology, Jefferson Medical College, Philadelphia, PA)
|
The Effect of Uterine Fibroids on Pregnancy Outcomes
|
Abstract |
| J Goldberg*, A Bussard, J McNeil, J Diamond (Department of Obstetrics and
Gynecology Jefferson Medical College, Philadelphia, PA)
|
Cost and Reimbursement for Three Fibroid Treatments: Hysterectomy,
Myomectomy, and Uterine Fibroid Embolization
|
Abstract |
| *D’Aloisio AA (University of North Carolina at Chapel Hill), Baird DD, Dunson DB
|
Association of Alcohol Intake With Incidence of Uterine Fibroids
|
Abstract |
| G Wegienka*, S Havstad, M Jankowski (Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, Michigan)
|
Estimating Incident Uterine Leiomyoma Diagnosis in an HMO
|
Abstract |
| G Wegienka*, DD Baird, DS Cousins (Department of Biostatistics and Research
Epidemiology, Henry Ford Health System, Detroit, Michigan)
|
Self-report of Uterine Leiomyoma Size Versus Ultrasound Evidence
|
Abstract |
| M Kuppermann*, LA Learman, E Gates, C Wassel Fyr, J Lewis, AE Washington (UCSF)
|
Health-Related Quality of Life and other Predictors of Hysterectomy
Use in a Diverse Population of Women with Fibroids
|
Abstract |
Animal Models
|
Presenter(s)
|
Presentation
|
Abstract
|
| FS Khan, C Moor, GB Hubbard (Department of Pathology, West Virginia School of Medicine, Morgantown, WV)
|
Chromosomal Analyses of Leiomyoma from the Nonhuman Primates: The
Chimpanzee and Macaque
|
Abstract |
| FS Khan, GB Hubbard (Department of Pathology, West Virginia University School of Medicine, Morgantown, WV)
|
Characterization of Uterine Leiomyoma in the Nonhuman Primate: The Baboon
|
Abstract |
| NG Manning, N Spoelstra, KB Horwitz, AP Bradford, KR Shroyer, and JK Richer*(Dept of Medicine, Div of Endocrinology, University of Colorado Health Sciences Center)
|
ZEB1 in Normal Myometrium, Leiomyomas and Leiomyosarcomas
|
Abstract |
| K Mozzachio*, AB Moore, N Clayton, G Kissling, and D Dixon (National Institute of Environmental Health Sciences, NIH, RTP, NC)
|
Estrogen Receptor-Alpha (ER- á) Immunoexpression in Uterine Leiomyomas and
Matched Myometria in Potbellied Pigs (Sus scrofa)
|
Abstract |
Growth Related
|
Presenter(s)
|
Presentation
|
Abstract
|
| BJ Davis, KT Miner*, KE Haneke, HL Vahdat, PE Blackshear, DD Baird, and SD Peddada (NIEHS, RTP, NC)
|
Assessment of Uterine Leiomyomas in the Fibroid Growth Study (FGS) using
Histological Sampling Methods
|
Abstract |
| JP Guyon*, S Aylward, KE Haneke, HL Vahdat, K Miner, SD Peddada, BJ Davis (ILS, Inc., RTP, NC)
|
Volume Estimation and Tracking Over Time (VETOT): Framework and application to the Fibroid Growth Study (FGS)
|
Abstract |
| KE Haneke*, BJ Davis, SD Peddada, K Miner, DD Baird, HL Vahdat, JP Guyon, M Wood, R Semelka, A Kowalik, JC Barrett (ILS, Inc., RTP, NC)
|
The Fibroid Growth Study (FGS): General Overview
|
Abstract |
Top
|
